[Immunotherapy of cancer: evolution of concepts and clinical advances]

[Article in French]

[Article in French]

R W Baldwin. Rev Prat. 1980.

. 1980 Jan 21;30(5):221-4, 227-8.

No abstract available

Similar articles

[Management of acute leukemias and linphosarcomas with active immunotherapy (author's transl)].
Mathe G, Amiel JL, Schwarsenberg L, Hyat M, Pouillart P, Schenider M, Cattan A, Jasmin C, Belpomme D, Schulmberger JR, De Vassal F, Musset M, Misset JL. Mathe G, et al. Folia Clin Int (Barc). 1975 Mar;25(3):131-51. Folia Clin Int (Barc). 1975. PMID: 1056311 Spanish. No abstract available.
[Considerations on some cases of acute lymphatic leukemia treated with aspecific active immunotheraphy].
Saggese V, Zanda G. Saggese V, et al. Minerva Pediatr. 1974 Jun 16;26(21):1087-93. Minerva Pediatr. 1974. PMID: 4526571 Italian. No abstract available.
Immunotherapy of cancer in man: current status and prospectus.
Carter SK. Carter SK. Ann N Y Acad Sci. 1976;277(00):722-40. doi: 10.1111/j.1749-6632.1976.tb41745.x. Ann N Y Acad Sci. 1976. PMID: 793477 Review. No abstract available.
The role of immunotherapy in acute myelogenous leukemia.
Foon KA, Smalley RV, Riggs CW, Gale RP. Foon KA, et al. Arch Intern Med. 1983 Sep;143(9):1726-31. Arch Intern Med. 1983. PMID: 6577818
[Immunotherapy of lung cancer].
Jassem J, Jassem E. Jassem J, et al. Pol Tyg Lek. 1982 Jun 14;37(17):497-9. Pol Tyg Lek. 1982. PMID: 6292882 Review. Polish. No abstract available.